IBD DIALOGUE

Read Now

Nov 22, 2022 -

Celiac disease & IBD

Read Now

Nov 8, 2022 -

Subclinical inflammation & CD progression

Read Now

Oct 18, 2022 -

Predicting relapse after stopping anti-TNF

Read Now

Oct 4, 2022 -

Corticosteroids & perinatal outcomes

Read Now

Sep 20, 2022 -

Histological activity & relapse in UC

Read Now

Sep 7, 2022 -

Anxiety / depression & IBD outcomes

Read Now

Aug 23, 2022 -

Cigarettes & colorectal neoplasia in IBD

Read Now

Aug 9, 2022 -

Impact of in utero exposure to IBD treatment

Read Now

Jul 19, 2022 -

COVID-19 vaccination in IBD patients

Read Now

Jul 12, 2022 -

Proactive TDM vs. conventional IBD management

Read Now

Jun 21, 2022 -

Postop complications & anti-TNFs

Read Now

Jun 7, 2022 -

ARFID & IBD

Read Now

May 24, 2022 -

Pediatric-onset IBD & risk of cancer

Read Now

May 10, 2022 -

Impact of HIV on IBD

Read Now

Apr 26, 2022 -

Disease duration & efficacy of biologics

Read Now

Apr 12, 2022 -

COVID-19 vaccine efficacy in IBD

Read Now

Mar 29, 2022 -

Risk of subsequent anti-TNF antibodies

Read Now

Mar 15, 2022 -

Predictors of pediatric CD relapse

Read Now

Feb 22, 2022 -

Rectal cancer in the diverted rectum

Read Now

Feb 8, 2022 -

Impact of fluctuating antibodies to infliximab

Read Now

Jan 18, 2022 -

Mortality in older IBD inpatients

Read Now

Jan 4, 2022 -

Assisted reproduction in IBD